{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T22:28:15Z","timestamp":1773181695066,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005149","name":"Cancer Hospital Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005149","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2024-I2M-C"],"award-info":[{"award-number":["2024-I2M-C"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["T-B-070"],"award-info":[{"award-number":["T-B-070"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.humpath.2025.105930","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:06:21Z","timestamp":1757549181000},"page":"105930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinicopathological characteristics and immune infiltration analysis of esophagogastric junction adenocarcinoma with alterations in SWI\/SNF complex"],"prefix":"10.1016","volume":"164","author":[{"given":"Na","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liyan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.humpath.2025.105930_bib1","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1073\/pnas.91.8.2905","article-title":"Five SWI\/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement","volume":"91","author":"Peterson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.humpath.2025.105930_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1053\/j.semdp.2020.11.001","article-title":"SWI\/SNF-deficient cancers of the gastroenteropancreatic tract: an in-depth review of the literature and pathology","volume":"38","author":"Nowak","year":"2021","journal-title":"Semin Diagn Pathol"},{"issue":"7","key":"10.1016\/j.humpath.2025.105930_bib3","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nrc3068","article-title":"SWI\/SNF nucleosome remodellers and cancer","volume":"11","author":"Wilson","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"7","key":"10.1016\/j.humpath.2025.105930_bib4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","article-title":"The SWI\/SNF complex in cancer - biology, biomarkers and therapy","volume":"17","author":"Mittal","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/his.14096","article-title":"Loss of switch\/sucrose non-fermenting complex protein expression in undifferentiated gastrointestinal and pancreatic carcinomas","volume":"77","author":"Tessier-Cloutier","year":"2020","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.humpath.2025.105930_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1097\/PAS.0000000000001836","volume":"46","author":"Chang","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1186\/s12957-022-02847-0","article-title":"Clinicopathological and prognostic significance of SWI\/SNF complex subunits in undifferentiated gastric carcinoma","volume":"20","author":"Zhang","year":"2022","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.humpath.2025.105930_bib8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1111\/cas.14301","article-title":"Solid-type poorly differentiated adenocarcinoma of the stomach: deficiency of mismatch repair and SWI\/SNF complex","volume":"111","author":"Tsuruta","year":"2020","journal-title":"Cancer Sci"},{"issue":"4","key":"10.1016\/j.humpath.2025.105930_bib9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s00428-022-03288-6","article-title":"Dedifferentiation-like tubular and solid carcinoma of the stomach shows phenotypic divergence and association with deficient SWI\/SNF complex","volume":"480","author":"Huang","year":"2022","journal-title":"Virchows Arch"},{"issue":"6","key":"10.1016\/j.humpath.2025.105930_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100183","article-title":"SMARCA4 mutations in carcinomas of the esophagus, esophagogastric junction, and stomach","volume":"36","author":"Neil","year":"2023","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.humpath.2025.105930_bib11","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/his.14117","article-title":"The clinicopathological and molecular analysis of gastric cancer with altered SMARCA4 expression","volume":"77","author":"Huang","year":"2020","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.humpath.2025.105930_bib12","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/PAT.0000000000000276","article-title":"Clinicopathological characterisation of small (2 Cm or less) proximal and distal gastric carcinomas in a Chinese population","volume":"47","author":"Huang","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.humpath.2025.105930_bib13","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12885-015-1021-7","article-title":"Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas","volume":"15","author":"Li-Chang","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humpath.2025.105930_bib14","article-title":"The distinct impact of TAM infiltration on the prognosis of patients with cardia and non-cardia gastric cancer and its association with H. pylori infection","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000519602","article-title":"Epidemiological review of gastroesophageal junction adenocarcinoma in Asian countries","volume":"103","author":"Manabe","year":"2022","journal-title":"Digestion"},{"issue":"12","key":"10.1016\/j.humpath.2025.105930_bib16","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1136\/gutjnl-2014-308915","article-title":"Global patterns of cardia and non-cardia gastric cancer incidence in 2012","volume":"64","author":"Colquhoun","year":"2015","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib17","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/nyas.13954","article-title":"Cancer of the gastroesophageal junction: a diagnosis, classification, and management review","volume":"1434","author":"Chevallay","year":"2018","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.humpath.2025.105930_bib18","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/1751-2980.12945","article-title":"Unraveling the identity of gastric cardiac cancer","volume":"21","author":"Huang","year":"2020","journal-title":"J Dig Dis"},{"issue":"11","key":"10.1016\/j.humpath.2025.105930_bib19","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41568-020-0285-7","article-title":"The immune contexture and immunoscore in cancer prognosis and therapeutic efficacy","volume":"20","author":"Bruni","year":"2020","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-019-1929-9","article-title":"Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies","volume":"17","author":"Liu","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.humpath.2025.105930_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2020.102015","article-title":"The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target","volume":"86","author":"Gambardella","year":"2020","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.humpath.2025.105930_bib22","doi-asserted-by":"crossref","DOI":"10.4238\/gmr15049040","article-title":"Prognostic significance of tumor-associated macrophage infiltration in gastric cancer: a meta-analysis","volume":"15","author":"Wang","year":"2016","journal-title":"Genet Mol Res : GMR"},{"issue":"15","key":"10.1016\/j.humpath.2025.105930_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13153894","article-title":"Comprehensive immunohistochemical study of the SWI\/SNF complex expression status in gastric cancer reveals an adverse prognosis of SWI\/SNF deficiency in genomically stable gastric carcinomas","volume":"13","author":"Gl\u00fcckstein","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humpath.2025.105930_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.humpath.2020.09.006","article-title":"p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort","volume":"105","author":"Schoop","year":"2020","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105930_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the college of American pathologists, American Society for clinical pathology, and the American Society of clinical oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105930_bib26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.humpath.2025.105930_bib27","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.5858\/arpa.2018-0201-OA","article-title":"Screening for Lynch syndrome by immunohistochemistry of mismatch repair proteins: significance of indeterminate result and correlation with mutational studies","volume":"143","author":"Sarode","year":"2019","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"10.1016\/j.humpath.2025.105930_bib28","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1002\/cam4.5776","article-title":"SMARCA4 and SMARCE1 in gastric cancer: correlation with ARID1A, and microsatellite stability, and SMARCE1\/ERBB2 co-amplification","volume":"12","author":"Pries","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.humpath.2025.105930_bib29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00428-021-03261-9","article-title":"Tumor progression by epithelial-mesenchymal transition in ARID1A- and SMARCA4-aberrant solid-type poorly differentiated gastric adenocarcinoma","volume":"480","author":"Sasaki","year":"2022","journal-title":"Virchows Arch"},{"issue":"7","key":"10.1016\/j.humpath.2025.105930_bib30","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00432-022-03971-w","article-title":"Loss of ARID1A expression is associated with systemic inflammation markers and has important prognostic significance in gastric cancer","volume":"148","author":"Wang","year":"2022","journal-title":"J Cancer Res Clin Oncol"},{"issue":"16","key":"10.1016\/j.humpath.2025.105930_bib31","doi-asserted-by":"crossref","first-page":"16716","DOI":"10.1002\/cam4.6294","article-title":"Prognostic and immune infiltration significance of ARID1A in TCGA molecular subtypes of gastric adenocarcinoma","volume":"12","author":"Zhang","year":"2023","journal-title":"Cancer Med"},{"issue":"7517","key":"10.1016\/j.humpath.2025.105930_bib32","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.humpath.2025.105930_bib33","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1007\/s10147-023-02403-0","article-title":"Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model","volume":"28","author":"Zhang","year":"2023","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0245356","article-title":"The clinicopathological significance of SWI\/SNF alterations in gastric cancer is associated with the molecular subtypes","volume":"16","author":"Huang","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2025.105930_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2022.05.001","article-title":"SMARCA4-deficient lung carcinoma is an aggressive tumor highly infiltrated by FOXP3+ cells and neutrophils","volume":"169","author":"Velut","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.humpath.2025.105930_bib36","article-title":"Phosphorylation of Ser1452 on BRG1 inhibits the function of the SWI\/SNF complex in chromatin activation","volume":"247","author":"Kimura","year":"2021","journal-title":"J Proteonomics"},{"issue":"5","key":"10.1016\/j.humpath.2025.105930_bib37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5009\/gnl220342","article-title":"Prognostic significance of ARID1A expression patterns varies with molecular subtype in advanced gastric cancer","volume":"17","author":"Kim","year":"2023","journal-title":"Gut Liver"},{"key":"10.1016\/j.humpath.2025.105930_bib38","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejca.2020.09.006","article-title":"The impact of ARID1A mutation on molecular characteristics in colorectal cancer","volume":"140","author":"Tokunaga","year":"2020","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12916-024-03257-7","article-title":"Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma","volume":"22","author":"Yang","year":"2024","journal-title":"BMC Med"},{"issue":"19","key":"10.1016\/j.humpath.2025.105930_bib40","doi-asserted-by":"crossref","first-page":"17529","DOI":"10.1007\/s00432-023-05471-x","article-title":"Explore the alterations of downstream molecular pathways caused by ARID1A mutation\/knockout in human endometrial cancer cells","volume":"149","author":"Xing","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"issue":"13","key":"10.1016\/j.humpath.2025.105930_bib41","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.cell.2024.04.025","article-title":"ARID1A suppresses R-loop-mediated STING-type I interferon pathway activation of anti-tumor immunity","volume":"187","author":"Maxwell","year":"2024","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.humpath.2025.105930_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010069","article-title":"Genetic and therapeutic heterogeneity shape the baseline and longitudinal immune ecosystem of ovarian clear cell carcinoma","volume":"12","author":"Xia","year":"2024","journal-title":"J Immunother Cancer"},{"issue":"4","key":"10.1016\/j.humpath.2025.105930_bib43","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/path.5849","article-title":"Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8(+) TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas","volume":"256","author":"Heinze","year":"2022","journal-title":"J Pathol"},{"key":"10.1016\/j.humpath.2025.105930_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107499","article-title":"ARID1A is a coactivator of STAT5 that contributes to CD8(+) T cell dysfunction and anti-PD-1 resistance in gastric cancer","volume":"210","author":"Ma","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.humpath.2025.105930_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.762598","article-title":"A pan-cancer analysis of SMARCA4 alterations in human cancers","volume":"12","author":"Peng","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.humpath.2025.105930_bib46","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13000-021-01091-6","article-title":"Undifferentiated colonic neoplasm with SMARCA4 germline gene mutation and loss of SMARCA4 protein expression: a case report and literature review","volume":"16","author":"Duan","year":"2021","journal-title":"Diagn Pathol"},{"issue":"21","key":"10.1016\/j.humpath.2025.105930_bib47","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/1078-0432.CCR-20-1825","article-title":"The genomic landscape of SMARCA4 alterations and associations with outcomes in patients with lung cancer","volume":"26","author":"Schoenfeld","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"7","key":"10.1016\/j.humpath.2025.105930_bib48","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.jtho.2021.03.024","article-title":"SMARCA4 and other SWItch\/Sucrose NonFermentable family genomic alterations in NSCLC: clinicopathologic characteristics and outcomes to immune checkpoint inhibition","volume":"16","author":"Alessi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"4","key":"10.1016\/j.humpath.2025.105930_bib49","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/ijc.32140","article-title":"Functional loss of ARID1A is tightly associated with high PD-L1 expression in gastric cancer","volume":"145","author":"Kim","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2025.105930_bib50","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.humpath.2019.09.016","article-title":"Intratumoral heterogeneity and loss of ARID1A expression in gastric cancer correlates with increased PD-L1 expression in Western patients","volume":"94","author":"Tober","year":"2019","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725002175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:20:17Z","timestamp":1773112817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725002175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"alternative-id":["S0046817725002175"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105930","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinicopathological characteristics and immune infiltration analysis of esophagogastric junction adenocarcinoma with alterations in SWI\/SNF complex","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105930"}}